Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01)
- 8 October 2020
- journal article
- research article
- Published by Elsevier BV in Endocrine
- Vol. 109 (3), 701-711
- https://doi.org/10.1016/j.ijrobp.2020.09.059
Abstract
No abstract availableFunding Information
- National Medical Research Council
This publication has 19 references indexed in Scilit:
- A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal CarcinomatosisClinical Cancer Research, 2015
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III TrialJournal of Clinical Oncology, 2014
- Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology GroupGynecologic Oncology, 2011
- The Effects of G2-Phase Enrichment and Checkpoint Abrogation on Low-Dose Hyper-RadiosensitivityEndocrine, 2010
- Whole abdominal radiotherapy in ovarian cancerReports of Practical Oncology and Radiotherapy, 2010
- Low-Dose Hyper-Radiosensitivity: Past, Present, and FutureEndocrine, 2008
- Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: Impact of DNA repairInternational Journal of Radiation Biology, 2008
- Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous CancerJournal of Clinical Oncology, 2007
- The Management of Recurrent Ovarian CancerSeminars in Oncology, 2007
- Effects of cell cycle phase on low-dose hyper-radiosensitivityInternational Journal of Radiation Biology, 2003